UCLA Alpha Clinic

Patient being seen by physician

The UCLA Alpha Clinic’s mission is to deliver cutting-edge cell and gene therapies to patients in need, regardless of their race, gender, age, socioeconomic status or geographic location.  

The clinic works to achieve this by providing the infrastructure and expertise investigators need to launch and conduct clinical trials testing potentially life-saving stem cell-based therapies in a safe, equitable and efficient manner. 

Our center provides funding and support to the UCLA Alpha Clinic in partnership with the UCLA Clinical and Translational Science InstituteUCLA Health and the UCLA David Geffen School of Medicine

Visit the UCLA Alpha Clinic to learn more and to see a list of active clinical trials. 

To learn more about clinical therapies using stem cells and the availability of stem cell clinical trials beyond UCLA, the International Society for Stem Cell Research's Guide to Stem Cell Treatments is an excellent resource.

The UCLA Alpha Clinic is one of nine California Institute for Regenerative Medicine-funded clinics (alongside Cedars-Sinai, City of Hope, UC Davis, UC Irvine, UC San Diego, UC San Francisco, the University of Southern California and Stanford University), which together comprise the CIRM Alpha Clinics Network.

For a complete list of clinical trials across the CIRM Alpha Clinics Network, visit CIRM's Alpha Clinics Trials page.

Clinic History

UCLA’s Alpha Clinic launched in 2015 as one of three inaugural sites in CIRM’s Alpha Clinics Network. Over its first five years, the clinic chaperoned 28 highly innovative stem cell and gene therapies to Phase 1 and/or Phase 2 clinical trials. In 2022, UCLA received a new CIRM grant to expand patient access to clinical trials and strengthen health education, workforce development and community care initiatives.